Arsenic Trioxide Induces Apoptosis in Human Colorectal Adenocarcinoma HT-29 Cells Through ROS

Young Cha; Dae-Weon Park; Chu Hee Lee; Suk-Hwan Baek; Seong-Yong Kim; Jae-Ryong Kim; Jung Hye Kim

doi:10.4143/crt.2006.38.1.54

Articles

Page Path: HOME > Cancer Res Treat > Volume 38(1); 2006 > Article

Original Article Arsenic Trioxide Induces Apoptosis in Human Colorectal Adenocarcinoma HT-29 Cells Through ROS: Young Cha^1,2, Dae-Weon Park^1,2, Chu Hee Lee, Ph.D.^1,2, Suk-Hwan Baek, Ph.D.^1,2, Seong-Yong Kim, M.D., Ph.D.¹, Jae-Ryong Kim, M.D., Ph.D.^1,2, Jung Hye Kim, M.D., Ph.D.¹; Cancer Research and Treatment : Official Journal of Korean Cancer Association 2006;38(1):54-60.
DOI: https://doi.org/10.4143/crt.2006.38.1.54
Published online: February 28, 2006

¹Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu, Korea.

²Aging-Associated Vascular Disease Research Center, College of Medicine, Yeungnam University, Daegu, Korea.

Correspondence: Jung Hye Kim, Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, 317-1 Daemyung-dong, Nam-gu, Daegu 705-717, Korea. (Tel) 82-53-620-4340, (Fax) 82-53-654-6651, jhykim@med.yu.ac.kr

• Received: February 1, 2006 • Accepted: February 28, 2006

11,584 Views
52 Download
9 Crossref

Full Article

Download PDF

Abstract

Purpose
Treatment with arsenic trioxide (As₂O₃) results in a wide range of cellular effects that includes induction of apoptosis, inhibition of cell growth, promotion or inhibition of cellular differentiation, and inhibition of angiogenesis through a variety of mechanisms. The mechanisms of As₂O₃-induced cell death have been mainly studied in hematological cancers, and those mechanisms in solid cancers have yet to be clearly defined. In this study, the mechanisms by which As₂O₃ induces apoptosis in human colorectal adenocarcinoma HT-29 cells were investigated.
Materials and Methods
To examine the levels of apoptosis, HT-29 cells were treated with As₂O₃ and then we measured the percentage of Annexin V binding cells, the amount of ROS production and the mitochondrial membrane potential. Western blot analysis was performed to identify the activated caspases after As₂O₃ exposure, and we compared the possible target molecules of apoptosis. As₂O₃ treatment induced the loss of the mitochondrial membrane potential and an increase of ROS, as well as activation of caspase-3, -7, -9 and -10.
Results
As₂O₃ induced apoptosis via the production of reactive oxygen species and the loss of the mitochondrial membrane potential. As₂O₃ induced the activation of caspase-3, -7, -9 and -10. Furthermore, As₂O₃ treatment downregulates the Mcl-1 and Bcl-2 expressions, and the release of cytochrome c and an apoptosis-inducing factor (AIF). Pretreating the HT-29 cells with N-acetyl-L-cysteine, which is a thiol-containing antioxidant, inhibited the As₂O₃-induced apoptosis and caspase activation.
Conclusion
Taken together, these results suggest that the generation of reactive oxygen species (ROS) by As₂O₃ might play an important role in the regulation of As₂O₃-induced apoptosis. This cytotoxicity is mediated through a mitochondria-dependent apoptotic signal pathway in HT-29 cells.
Key words: Apoptosis, Arsenic trioxide, Mitochondria, Reactive oxygen species

INTRODUCTION

Arsenic trioxide (As₂O₃) has been used as a therapeutic agent for treating hypertension, bleeding gastric ulcers, heartburn, chronic rheumatism and cancer in the Orient countries (1). As₂O₃ has a long history of use for the treatment of leukemia, and it was recently approved for the treatment of relapsed or refractory acute promyelocytic leukemia (APL) by the US Food and Drug Administration (2). Treating APL patients with As₂O₃ is associated with the disappearance of the promyelocytic leukemia-retinoic acid receptor α (PML-RARα) fusion transcript; this is the gene product of the chromosomal translocation t (15;17), which is characteristic of APL (3). In addition, several in vitro studies revealed that As₂O₃ induces apoptosis in APL cells, multiple myeloma cells and some solid tumor cells such as prostate, ovarian carcinoma and neuroblastoma cells (4). Despite of the extensive investigations that have been conducted, the molecular mechanism of As₂O₃-induced apoptosis in solid tumors is not yet fully understood.

Programmed cell death or apoptosis is a physiological process that plays an important role in the maintenance of cellular homeostasis via the selective elimination of excessive cells (5). Apoptotic cells show the characteristic morphological changes that include cell shrinkage, chromatin condensation, nuclear fragmentation, membrane blebbing, caspase activation and the formation of membrane bound vesicles that are called apoptotic bodies (6). Aberrant regulation of apoptosis has been observed in many forms of human disease including cancers, AIDS and many neurodegenerative diseases (7). Therefore, understanding the mechanism of apoptosis has important implications for the prevention and treatment of many diseases.

Reactive oxygen species (ROS) play important roles in a variety of normal cellular biochemical functions and abnormal pathological processes. The biological functions of ROS and their potential roles in the development of cancers and disease progression have been investigated for decades (8~9). Evidence from recent studies suggests that cancer cells, as compared to normal cells, are under increased oxidative stress that is associated with the increased generation of ROS (10). Because ROS are chemically active and they can inflict severe cellular damage, the possibility that cancer cells are under increased intrinsic ROS stress may provide a unique opportunity to destroy malignant cells based on their vulnerability to further ROS insults (11).

Although the mechanisms of As₂O₃-induced cell death have mainly been studied in hematologic cancers, those studies have not clearly defined a role for As₂O₃ in solid tumors. In the present study, we have investigated As₂O₃'s induction of apoptosis in human colorectal adenocarcinoma cells, and we have elucidated the regulatory mechanism of apoptosis via As₂O₃, by focusing on the generation of ROS.

MATERIALS AND METHODS

1) Materials

As₂O₃, MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazoliumbromide) and N-acetyl-L-cysteine (NAC) were obtained from Sigma (St. Louis, MO). Annexin V-FITC was purchased from Becton Dickson (San Diego, CA). The enhanced chemiluminescence (ECL) detection system was purchased from Amersham Biosciences (Buckinghamshire, UK). RPMI 1640 was purchased from Life Technologies, Inc. (Gaithersburg, MD), and fetal bovine serum was purchased from Hyclone (Logan, Utah). Antibodies against caspase-3, -7, -9 and -10 were obtained from Cell Signaling Technology (Beverly, MA) and the antibodies against Mcl-1, Bcl-2 and apoptosis-inducing factor (AIF) were from Santa Cruz Biotechnology (Santa Cruz, CA). The antibody against cytochrome c was purchased from Pharmigen (San Diego, CA), and antibody against glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was purchased from Chemicon (Temecula, CA).

2) Cell culture

HT-29 human colorectal adenocarcinoma cells were obtained from the American Type Culture Collection (Rockville, MD). The cells were maintained in RPMI 1640 supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 10% heat inactivated fetal bovine serum, and they were grown at 37℃ in 5% CO₂ fully humidified air; they were subcultured twice weekly.

3) Cell viability assay

Cells (5×10³ cells/well) were cultured in 96-well microplates and treated with As₂O₃ in the presence or absence of various concentrations of inhibitors. After incubating the plates for 48 h, 50 µl of MTT (2 mg/ml) was added and the plates were incubated for an additional 4 h under the same conditions. During the final 4 h of incubation, the yellow MTT tetrazolium salt is reduced to purple-blue formazan crystals in only the viable cells. Formazan crystals were dissolved by adding 250 µl DMSO and the absorbance, which is linearly related to the number of viable cells, was measured at 570 nm on a BioRad M450 microplate reader. The cell death rate was expressed as a percentage of untreated control cells.

4) Annexin V-FITC staining

To detect early apoptosis, the cells were stained with FITC-conjugated Annexin V. After treatment with or without As₂O₃, the cells were washed with cold PBS before being resuspended in a 100 µl cold binding buffer. Five microliters of Annexin V-FITC were added and the incubation was continued for 15 min at room temperature and in the dark. A further 400 µl of binding buffer were added to terminate the reaction; flow cytometry analysis was then performed immediately for at least 10,000 cells by using a fluorescence-activated cell-sorting (FACS) analysis system (Becton Dickinson, San Jose, CA).

5) Measurement of ROS production

Cells were treated with the indicated concentrations of As₂O₃ for 48 h. Cells were incubated in 10 µM 2',7'-dichlorodihydrofluorescein diacetate (H₂DCF-DA) (Molecular Probes, Eugene, OR) at 37℃ for 20 min. The cells were harvested by trypsinization and washed twice with cold PBS. The ROS were determined by FACS analysis.

6) Determination of mitochondrial membrane potentials

The mitochondrial membrane potentials were measured using JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide; Molecular Probes, Eugene, OR), which is based on staining live cells in a membrane potential-dependent fashion: green fluorescence (λ_em=527 nm) was the results of the JC-1 monomer and red fluorescence (λ_em=590 nm) was the result of the JC-1 aggregates (12). Briefly, the cells (3×10⁵ cells/well) were treated with As₂O₃ for 48 h and then washed twice with PBS. The cell suspension was incubated with JC-1 (10 µg/ml) dye for 30 min at 37℃; the green (FL-1) and red (FL-2) fluorescence was then measured by FACS analysis.

7) Isolation of the cytosolic and mitochondrial fractions

The cells were washed once with cold PBS and then they were resuspended with 5 volumes of an isolation buffer (250 mM sucrose containing 20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl₂, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol and 0.1 mM PMSF). After chilling on ice for at least 20 min, the cells were homogenized with 30~40 strokes of a Dounce homogenizer (70~80% cell breakage), and the homogenates were centrifuged at 750 g for 10 min at 4℃ to remove the unbroken cells and nuclei. The supernatants were harvested and centrifuged at 12,000 g for 30 min at 4℃ (the cytosolic fraction). The mitochondria-enriched pellets were resuspended in isolation buffer. The cytosolic and mitochondrial fractions were then subjected to electrophoresis and Western blot analysis.

8) SDS-PAGE and Western blot analysis

The cells were washed twice in cold PBS and lysed on ice with lysis solution (1% Triton X-100, 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM PMSF and a protease inhibitor cocktail). The protein concentrations were determined using the BioRad protein assay according to the manufacturer's recommendations. The protein samples (30 µg of each) were separated on 10% SDS-polyacrylamide gel and electrotransferred to nitrocellulose membranes. The membranes were blocked for at least 30 minutes at room temperature in Tris-buffered saline plus 0.05% Tween-20 (TTBS) that contained 5% nonfat dry milk, and then the membranes were incubated with TTBS that contained a primary antibody. For immunoblotting, incubation was performed for 4 h at room temperature. After five washes within a 30 minute period, the membranes were incubated with a peroxidase-conjugated secondary antibody for 1 h. After five washes within a 30 minute period in TTBS, the membranes were developed using an ECL detection system and then they were exposed to X-ray films.

RESULTS

1) Effects of As₂O₃ on the apoptotic cell death of HT-29 cells

We examined the cytotoxic effect of As₂O₃ on human colorectal adenocarcinoma HT-29 cells. Treatment with As₂O₃ caused decreases in cell survival in a dose- and time-dependent manner (Fig. 1). To investigate whether the As₂O₃-induced cytotoxicity is mediated by apoptosis, we measured the Annexin V staining, ROS production, the mitochondrial membrane potential (Δψ_m) changes and the caspase cleavages in the cells that were treated with As₂O₃. Annexin V binds to the membrane phospholipid phosphatidylserine that is located within the plasma membrane of apoptotic cells. The percentage of cells stained with Annexin V was increased with the increasing concentrations of As₂O₃ (Fig. 2A). Since oxidative damage plays an important role in the anticancer effects of arsenic compounds (13), the intracellular generation of ROS in the HT-29 cells treated with As₂O₃ was investigated using an oxidation-sensitive fluorescent probe (H₂DCF-DA), which is oxidized to 2',7'-dichlorofluorescein (DCF) in the presence of ROS. Treatment with As₂O₃ led to an increase of the DCF fluorescence in a dose-dependent manner (Fig. 2B). Since the production of ROS is usually preceded or accompanied with the loss of Δψ_m, we also examined whether As₂O₃ treatment induces the loss of Δψ_m in the HT-29 cells that had been treated with As₂O₃ by performing staining with JC-1. As expected, the As₂O₃ treatment induced the loss of the Δψ_m in a dose-dependent manner (Fig. 2C). The likely involvement of caspases in the As₂O₃-induced apoptosis of HT-29 cells was analyzed by performing Western blot analysis. The treatment of cells with As₂O₃ caused the activation of caspase-3, -7, -9 and -10 in a dose- and time-dependent manner, as indicated by a reduction in the intensity of the proenzymes (Fig. 2D). In addition, degradation of PARP, which a well-known substrate of caspase-3, increased in the cells treated with As₂O₃. However, the expression level of caspase-8 between the As₂O₃-treated and As₂O₃-untreated cells was not altered (data not shown). These results suggest that As₂O₃ might induce apoptotic cell death in HT-29 cells.

2) Analysis of mitochondrial participation in As₂O₃-induced apoptosis

A key event in the apoptotic process is the opening of the mitochondrial permeability transition pores, and this is an event that's known to be regulated by the Bcl-2 family of proteins. The outcome of this opening is the release of several proteins such as procaspase-2, -3 and -9, cytochrome c and AIF from the mitochondrial intermembrane space (14). The expression level of Mcl-1 protein was significantly decreased in the As₂O₃-treated cells and the Bcl-2 protein level was slightly decreased (Fig. 3A). The release of cytochrome c from the mitochondria was also increased in the As₂O₃-treated cells compared to the untreated cells. The cells treated with As₂O₃ showed an increased amount of released AIF from the mitochondria into the cytosol (Fig. 3B). These results suggest that As₂O₃ might induce cellular apoptosis through a mitochondria-dependent apoptotic pathway.

3) Effect of antioxidant on the apoptotic activity of As₂O₃

To determine a link between the elevation of the intracellular ROS level and the apoptotic cell death in the As₂O₃ treated cells, HT-29 cells were incubated with NAC prior to their treatment with As₂O₃. NAC pretreatment resulted in protection against the As₂O₃-induced cytotoxicity (Fig. 4). The As₂O₃-induced increases of Annexin V staining, the intracellular ROS levels and the Δψ_m were reduced by the NAC pretreatment (Fig. 5A and 5B). Furthermore, NAC inhibited the As₂O₃-induced caspase activation and PARP degradation (Fig. 5C). Yet the addition of NAC did not affect the As₂O₃-induced down-regulation of Mcl-1 and Bcl-2 (Fig. 5D). These results suggest that an increase in the intracellular ROS level by As₂O₃ treatment is required for the As₂O₃-induced apoptosis that is accompanied by the loss of Δψ_m, caspase activation and PARP degradation.

DISCUSSION

The aim of the present study was to elucidate the molecular mechanisms of cellular death that are triggered by As₂O₃ treatment with using human colorectal adenocarcinoma HT-29 cells. Our experiments indicated that ROS have an important role in the As₂O₃-induced caspase-dependent cell death of the HT-29 cells.

The caspase cascade is the most-studied and best-understood signaling pathway in apoptosis. These proteases are produced as forms of pro-enzymes, and they can be activated by proteolysis in response to a diverse set of apoptotic stimuli (15). One means of activating the caspase cascade is termed the "death-receptor pathway" and this is initiated at the cell surface by the binding of apoptotic molecules to their receptors (16). Caspase-8 and caspase-10 are the key initiator caspases in the "death-receptor pathway". The mitochondria are another site for apoptotic stimuli to initiate an intracellular signaling process that mediates caspase activation. In this case, caspase-9 functions as an initiator caspase that activates downstream effecter caspases such as caspase-3 (17). We found that cells treated with As₂O₃ show activation of caspase-3, -7, -9 and -10. Degradation of PARP was also observed in the As₂O₃-treated cells. Thus, these data suggest that the As₂O₃-induced apoptosis of HT-29 cells might be mediated through a mitochondria-dependent pathway.

The mitochondria have been shown to play a pivotal role in the apoptotic process since both the intrinsic and the extrinsic pathways can converge at the mitochondrial level and so trigger changes in the mitochondrial membrane permeability (18,19). Mutations in such apoptosis-regulatory genes as p53, PTEN and Bcl-2 and its homologues are involved in the pathogenesis of most human cancers (20). Similar mutations may also be involved in the development of chemoresistance. Bcl-2 has been shown to be protective against diverse cytotoxic insults, i.e., UV-irradiation and cytokine drugs, while the pro-apoptotic family members may also act as tumor suppressors (21). Mcl-1 also has sequence homology to Bcl-2 and it further resembles Bcl-2 since its expression promotes cell viability (22). It has been reported that AIF mediates mitochondria-related cell death through a caspase-independent pathway wherein the mitochondrial AIF translocates to the cell nucleus in response to death stimuli, and there it initiates nuclear condensation. Once the nucleus condenses, large-scale chromatin fragmentation ensues followed by death of the cell (4). In this study, As₂O₃ induced the release of cytochrome c and AIF, so it's possible that As₂O₃ induces mitochondria-mediated apoptosis by both the caspase-dependent and caspase-independent pathways.

Accumulation of intracellular ROS leads to the disruption of the Δψ_m, the release of cytochrome c with the subsequent activation of the caspase cascade, and ultimately to programmed cell death via apoptosis (23,24). Arsenic exposure leads to increases in the ROS levels by a variety of redox enzymes such as NADPH oxidase (25). In the present study, we showed that increased levels of ROS are essential for the loss of the Δψ_m and the caspase activation that's triggered by As₂O₃. The significant inhibition of As₂O₃-induced caspase activation and cell death after NAC treatment suggests that increased ROS levels are critical for As₂O₃-mediated apoptosis in HT-29 cells.

CONCLUSIONS

The data presented in this study suggest that the generation of ROS might be a critical factor for As₂O₃-induced apoptosis in human colorectal adenocarcinoma HT-29 cells, and that the As₂O₃-induced apoptosis could be induced by a mitochondria-mediated apoptotic pathway.

NOTES

This study was supported by the Korea Science and Engineering Foundation (KOSEF) through the Aging-associated Vascular Disease Research Center at Yeungnam University (R13-2005-005-01003-0 (2005).

REFERENCES

1. Zhang TD, Chen GQ, Wang ZG, Wang ZY, Chen SJ, Chen Z. Arsenic trioxide, a therapeutic agent for APL. Oncogene. 2001;20:7146–7153. PMID: 11704843Article PubMed
2. Antman KH. Introduction: the history of arsenic trioxide in cancer therapy. Oncologist. 2001;6(Suppl 2):1–2. PMID: 11331433Article
3. Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol. 2001;19:3852–3860. PMID: 11559723Article PubMed
4. Kang YH, Yi MJ, Kim MJ, Park MT, Bae S, Kang CM, et al. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly (ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 2004;64:8960–8967. PMID: 15604259Article PubMed
5. Bortner CD, Cidlowski JA. Cellular mechanisms for the repression of apoptosis. Annu Rev Pharmacol Toxicol. 2002;42:259–281. PMID: 11807173Article PubMed
6. Schmitt CA, Lowe SW. Apoptosis and therapy. J Pathol. 1999;187:127–137. PMID: 10341713Article PubMed
7. Fischer U, Schulze-Osthoff K. New approaches and therapeutics targeting apoptosis in disease. Pharmacol Rev. 2005;57:187–215. PMID: 15914467Article PubMed
8. Ferrari R, Guardigli G, Mele D, Percoco GF, Ceconi C, Curello S. Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des. 2004;10:1699–1711. PMID: 15134567Article PubMed
9. Honda K, Casadesus G, Petersen RB, Perry G, Smith MA. Oxidative stress and redox-active iron in Alzheimer's disease. Ann N Y Acad Sci. 2004;1012:179–182. PMID: 15105265Article PubMed
10. Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 2001;3:323–327. PMID: 11597322Article PubMed PMC
11. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004;7:97–110. PMID: 15158766Article PubMed
12. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6 (3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 1997;411:77–82. PMID: 9247146Article PubMed
13. Buzard GS, Kasprzak KS. Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis: a review. J Environ Pathol Toxicol Oncol. 2000;19:179–199. PMID: 10983886PubMed
14. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med. 1996;184:1331–1341. PMID: 8879205Article PubMed PMC
15. Cho SG, Choi EJ. Apoptotic signaling pathways: caspases and stress-activated protein kinases. J Biochem Mol Biol. 2002;35:24–27. PMID: 16248966Article PubMed
16. Kaufmann SH, Hengartner MO. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 2001;11:526–534. PMID: 11719060Article PubMed
17. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479–489. PMID: 9390557Article PubMed
18. Hockenbery DM, Giedt CD, O'Neill JW, Manion MK, Banker DE. Mitochondria and apoptosis: new therapeutic targets. Adv Cancer Res. 2002;85:203–242. PMID: 12374287Article PubMed
19. Henry-Mowatt J, Dive C, Martinou JC, James D. Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene. 2004;23:2850–2860. PMID: 15077148Article PubMed
20. Constantini P, Jacotot E, Decaudin D, Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst. 2000;92:1042–1053. PMID: 10880547Article PubMed
21. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322–1326. PMID: 9735050Article PubMed
22. Michels J, Johnson PW, Packham G. Mcl-1. Int J Biochem Cell Biol. 2005;37:267–271. PMID: 15474972Article PubMed
23. Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol. 1999;57:231–245. PMID: 9890550Article PubMed
24. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood. 1999;94:2102–2111. PMID: 10477740Article PubMed
25. Chou WC, Jie C, Kenedy AA, Jones RJ, Trush MA, Dang CV. Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci USA. 2004;101:4578–4583. PMID: 15070760Article PubMed PMC

Fig. 1

Effects of As₂O₃ on cell survival in human colorectal adenocarcinoma HT-29 cells. The cells were treated with increasing concentrations of As₂O₃. Cell survival was measured by the MTT assay. The values are the mean±SD of three independent experiments.

Fig. 2

Induction of apoptosis by As₂O₃-mediated cytotoxicity. The cells were treated with increasing concentrations of As₂O₃ for 48 h. The cells were incubated with Annexin V (A), H₂DCF-DA (B), or JC-1 (C), and then they were analyzed by flow cytometry. The cell lysates were further analyzed by Western blotting with using anti-caspase and anti-PARP antibodies (D). The GAPDH level was used to demonstrate equal loading of proteins on each lane.

Fig. 3

Effects of As₂O₃ on the levels of Mcl-1, Bcl-2, cytochrome c and AIF. The cells were treated with increasing concentrations of As₂O₃ for 48 h. The cell lysates were analyzed by Western blotting using anti-Mcl-1, anti-Bcl-2, anti-cytochrome c and anti-AIF antibodies. The GAPDH level was used to demonstrate equal loading of proteins on each lane.

Fig. 4

The effects of NAC on the As₂O₃-mediated cytotoxicity. The cells were treated with As₂O₃ in the presence or absence of NAC. After 48 h, cell survival was determined by the MTT assay. The values are the mean±SD of three independent experiments.

Fig. 5

The effects of NAC on As₂O₃-mediated apoptosis. The cells were treated with 5 mM NAC for 30 min and then they were treated with 20 µM As₂O₃ for an additional 48 h. The cells were incubated with Annexin V (A), H₂DCF-DA (B), or JC-1 (C) and next analyzed by flow cytometry. The cell lysates were analyzed by Western blotting with anti-caspase and anti-PARP antibodies (D). The GAPDH level was used to demonstrate equal loading of proteins on each lane.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Arsenic trioxide: applications, mechanisms of action, toxicity and rescue strategies to date
Meng Yan, Hao Wang, Rui Wei, Wenwen Li
Archives of Pharmacal Research.2024; 47(3): 249. CrossRef
Inorganic arsenic exposure promotes malignant progression by HDAC6‐mediated down‐regulation of HTRA1
Jiafeng Chen, Cece Lei, Daibang Nie, Huan Ge, Jian Li, Changbin Lei, Wang Wang
Journal of Applied Toxicology.2023; 43(8): 1214. CrossRef
Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer
Sangsang Tang, Yuanming Shen, Xinyi Wei, Zhangjin Shen, Weiguo Lu, Junfen Xu
Cell Death & Disease.2022;[Epub] CrossRef
Combination of Arsenic Trioxide and Valproic Acid Efficiently Inhibits Growth of Lung Cancer Cells via G2/M-Phase Arrest and Apoptotic Cell Death
Hyun Kyung Park, Bo Ram Han, Woo Hyun Park
International Journal of Molecular Sciences.2020; 21(7): 2649. CrossRef
Arsenic trioxide induces growth inhibition and death in human pulmonary artery smooth muscle cells accompanied by mitochondrial increase and GSH depletion
Woo Hyun Park, Bo Ran Han, Hyun Kyung Park, Sung Zoo Kim
Environmental Toxicology.2018; 33(8): 833. CrossRef
PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis
Qiao Yi Chen, Max Costa
Molecular Pharmacology.2018; 94(1): 784. CrossRef
Anticytotoxic and Radical Scavenging Activities of Acer tegmentosum Maxim Stem Extracts
Tae-Jin Rhim
Journal of Environmental Science International.2015; 24(11): 1315. CrossRef
Calpain and Reactive Oxygen Species Targets Bax for Mitochondrial Permeabilisation and Caspase Activation in Zerumbone Induced Apoptosis
Praveen K. Sobhan, Mahendra Seervi, Lokesh Deb, Saneesh Varghese, Anjana Soman, Jeena Joseph, Krupa Ann Mathew, Godi Raghu, George Thomas, Sreekumar E, Manjula S, Santosh Kumar T. R, Hiroyasu Nakano
PLoS ONE.2013; 8(4): e59350. CrossRef
Protective and antioxidant role of selenium on arsenic trioxide–induced oxidative stress and genotoxicity in the fish hepatoma cell line PLHC-1
Vellaisamy Selvaraj, Mindy Yeager-Armstead, Elizabeth Murray
Environmental Toxicology and Chemistry.2012; 31(12): 2861. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Arsenic Trioxide Induces Apoptosis in Human Colorectal Adenocarcinoma HT-29 Cells Through ROS

Cancer Res Treat. 2006;38(1):54-60. Published online February 28, 2006

DOI: https://doi.org/10.4143/crt.2006.38.1.54

XML Download

Abstract
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
NOTES
REFERENCES

Arsenic Trioxide Induces Apoptosis in Human Colorectal Adenocarcinoma HT-29 Cells Through ROS

Fig. 1 Effects of As2O3 on cell survival in human colorectal adenocarcinoma HT-29 cells. The cells were treated with increasing concentrations of As2O3. Cell survival was measured by the MTT assay. The values are the mean±SD of three independent experiments.

Fig. 2 Induction of apoptosis by As2O3-mediated cytotoxicity. The cells were treated with increasing concentrations of As2O3 for 48 h. The cells were incubated with Annexin V (A), H2DCF-DA (B), or JC-1 (C), and then they were analyzed by flow cytometry. The cell lysates were further analyzed by Western blotting with using anti-caspase and anti-PARP antibodies (D). The GAPDH level was used to demonstrate equal loading of proteins on each lane.

Fig. 3 Effects of As2O3 on the levels of Mcl-1, Bcl-2, cytochrome c and AIF. The cells were treated with increasing concentrations of As2O3 for 48 h. The cell lysates were analyzed by Western blotting using anti-Mcl-1, anti-Bcl-2, anti-cytochrome c and anti-AIF antibodies. The GAPDH level was used to demonstrate equal loading of proteins on each lane.

Fig. 4 The effects of NAC on the As2O3-mediated cytotoxicity. The cells were treated with As2O3 in the presence or absence of NAC. After 48 h, cell survival was determined by the MTT assay. The values are the mean±SD of three independent experiments.

Fig. 5 The effects of NAC on As2O3-mediated apoptosis. The cells were treated with 5 mM NAC for 30 min and then they were treated with 20 µM As2O3 for an additional 48 h. The cells were incubated with Annexin V (A), H2DCF-DA (B), or JC-1 (C) and next analyzed by flow cytometry. The cell lysates were analyzed by Western blotting with anti-caspase and anti-PARP antibodies (D). The GAPDH level was used to demonstrate equal loading of proteins on each lane.

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Arsenic Trioxide Induces Apoptosis in Human Colorectal Adenocarcinoma HT-29 Cells Through ROS